Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Stephen S. Hall Guest Contributor

  • That's Immortality!

    Embryonic stem cells could someday work like micoscopic fountains of youth. Then again, what’s so great about immortality?

  • Science Triumphs, Market Fails

    A new vaccine will guard American children agains rotavirus. But much of the world will be unable to afford the protection. What to do?

  • Science-Fiction Policy

    In an exaggerated response to a work of science fiction, the U.S. govenment is set to spend hundreds of millions to fight “bioterrism.” Is this any way to make public policy?

  • Miracles of Saint Judah

    When it comes to reporting on cancer “breakthroughs,” journalists fall back on the same old myths.

  • Blue-Collar Cell Therapy

    It’s possible now to grow cartilage cells in the lab and reintroduce them into human joints. Skiers and quarterbacks, take heart.

    1 comment


From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me